The Walter and Eliza Hall Institute of Medical Research-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:The Walter and Eliza Hall Institute of Medical Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013241
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
The Walter and Eliza Hall Institute of Medical Research (WEHI), a subsidiary of Melbourne Medical School The University of Melbourne is a medical research institute that conducts clinical research, and offers educational and contract research services. The institute develops therapeutics for the prevention and treatment of diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. It provides undergraduate, PhD, honors, and other programs. WEHI performs research in various fields such as bioinformatics, cancer biology, cell death, cell signaling, clinical translation, immunology, infection, inflammation, medicinal chemistry, stem cells, structural biology, systems biology and vaccine development. The institute operates through WEHI biotechnology center located in Bundoora, Australia. WEHI is headquartered in Parkville, Victoria, Australia.

The Walter and Eliza Hall Institute of Medical Research – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
The Walter and Eliza Hall Institute of Medical Research, Medical Devices Deals, 2011 to YTD 2017 9
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Servier Enters into Research Agreement with Walter and Eliza Hall Institute of Medical Research 11
ImmusanT Enters Into Research Agreement With Walter and Eliza Hall Institute of Medical Research 12
Licensing Agreements 13
TetraLogic Pharma Enters Into Licensing Agreement With Walter And Eliza Hall Institute Of Medical Research 13
The Walter and Eliza Hall Institute of Medical Research – Key Competitors 14
The Walter and Eliza Hall Institute of Medical Research – Key Employees 15
The Walter and Eliza Hall Institute of Medical Research – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
Nov 14, 2017: World Diabetes Day: funding boost for diabetes research 17
Nov 10, 2017: Short-circuiting dangerous immune cells to treat asthma 19
Nov 18, 2016: New quality control revealed in immune T cell development 20
May 17, 2016: Researchers reveal how a new class of drugs kills cancer cells 21
Feb 19, 2016: 3D protein map offers new malaria vaccine hope 22
Feb 19, 2016: Scientists discover secret to promising new cancer drug 23
Feb 12, 2016: Gene technology to help healthy skin in Aboriginal Australians 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare, Key Facts 2
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
The Walter and Eliza Hall Institute of Medical Research, Deals By Therapy Area, 2011 to YTD 2017 8
The Walter and Eliza Hall Institute of Medical Research, Medical Devices Deals, 2011 to YTD 2017 9
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Servier Enters into Research Agreement with Walter and Eliza Hall Institute of Medical Research 11
ImmusanT Enters Into Research Agreement With Walter and Eliza Hall Institute of Medical Research 12
TetraLogic Pharma Enters Into Licensing Agreement With Walter And Eliza Hall Institute Of Medical Research 13
The Walter and Eliza Hall Institute of Medical Research, Key Competitors 14
The Walter and Eliza Hall Institute of Medical Research, Key Employees 15
The Walter and Eliza Hall Institute of Medical Research, Other Locations 16

★海外企業調査レポート[The Walter and Eliza Hall Institute of Medical Research-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pilgrim’s Pride Corporation:企業の戦略・SWOT・財務情報
    Pilgrim's Pride Corporation - Strategy, SWOT and Corporate Finance Report Summary Pilgrim's Pride Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Peako Ltd (PKO):企業の財務・戦略的SWOT分析
    Summary Peako Ltd (Peako), formerly Peak Oil & Gas Ltd, is a mineral exploration company. The company carries out the business of acquisition, exploration, and development of gold, silver and copper metals. Its projects include East Kimberley Region and Paterson Province. Peako’s East Kimberley Regi …
  • Marathon Oil Corp (MRO):石油・ガス:M&Aディール及び事業提携情報
    Summary Marathon Oil Corp (MRO) is independent energy company, which explores, produces and markets liquid hydrocarbons and natural gas. It focuses mainly on unconventional resource plays in the US with operations in Africa and Europe. The company has properties in the major oil-rich resource plays …
  • BioTime Inc (BTX)-製薬・医療分野:企業M&A・提携分析
    Summary BioTime Inc (BioTime) is a biotechnology company which focuses on regenerative medicine and plasma volume expanders. The company’s Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. It is also develo …
  • Services Group of America:企業の戦略・SWOT・財務分析
    Services Group of America - Strategy, SWOT and Corporate Finance Report Summary Services Group of America - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Nabors Industries Ltd.:企業の戦略・SWOT・財務分析
    Nabors Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nabors Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Empresa Nacional de Hidrocarbonetos EP:石油・ガス:M&Aディール及び事業提携情報
    Summary Empresa Nacional de Hidrocarbonetos EP (ENH) is an oil and gas company that explores, produces and markets petroleum products. The company conducts research, exploitation, production, refining, transportation, storage and marketing of hydrocarbons and its derivatives such as liquefied natura …
  • Bancolombia SA (BCOLOMBIA):企業の財務・戦略的SWOT分析
    Bancolombia SA (BCOLOMBIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Invenergy LLC:企業の発電所・SWOT分析2018
    Invenergy LLC - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • SRI International:企業のM&A・事業提携・投資動向
    SRI International - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SRI International Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Abzena Plc (ABZA):製薬・医療:M&Aディール及び事業提携情報
    Summary Abzena Plc (Abzena), formerly Polytherics Group Ltd, is a life science company that provides complementary services and technologies to enable the selection, development and manufacture of biopharmaceuticals products based on antibodies and other proteins. The company's technologies include …
  • Antong Holdings Co., Ltd. (600179):企業の財務・戦略的SWOT分析
    Antong Holdings Co., Ltd. (600179) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Denbury Resources Inc (DNR):石油・ガス:M&Aディール及び事業提携情報
    Summary Denbury Resources Inc (Denbury) is an independent oil and natural gas company. It carries out exploration, development and production of oil and natural gas from its assets in the Gulf Coast and Rocky Mountain regions in the US. The company mainly focuses on enhanced oil recovery utilizing c …
  • Jordan Phosphate Mines Co. Plc.:企業の戦略・SWOT・財務情報
    Jordan Phosphate Mines Co. Plc. - Strategy, SWOT and Corporate Finance Report Summary Jordan Phosphate Mines Co. Plc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Broadspectrum (Australia) Pty Ltd:企業の戦略的SWOT分析
    Broadspectrum (Australia) Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Resonance Health Ltd (RHT):医療機器:M&Aディール及び事業提携情報
    Summary Resonance Health Ltd (Resonance Health) is a healthcare solution provider that offers non-invasive medical imaging software and services. The company offers FerriScan analysis software for the measurement of liver iron concentration (LIC); FerriScan with Cardiac T2* dual analysis service to …
  • PeriGen Inc-医療機器分野:企業M&A・提携分析
    Summary PeriGen Inc (PeriGen), formerly E&C Medical Intelligence Inc is a healthcare technology company that offers advanced obstetric decision-support systems. The company offers fetal monitoring systems which include tracings, patterns, curve and shoulder screen systems. Its decision-support softw …
  • Helix Energy Solutions Group Inc (HLX):企業の財務・戦略的SWOT分析
    Summary Helix Energy Solutions Group Inc (Helix Energy) is an oil and gas company that provides offshore energy services. The company provides well intervention, subsea engineering and contracting services. Its well intervention services comprise riserless intervention and riser based operations, st …
  • Glavbolgarstroy Holdings AD:企業の戦略・SWOT・財務情報
    Glavbolgarstroy Holdings AD - Strategy, SWOT and Corporate Finance Report Summary Glavbolgarstroy Holdings AD - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Belk Inc:企業の戦略・SWOT・財務情報
    Belk Inc - Strategy, SWOT and Corporate Finance Report Summary Belk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆